Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Neuronal acetylcholine receptor subunit alpha-7

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Hypertension

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Markwood, L.N.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

1

EPA CompTox

1

FDA UNII

1

MERCK INDEX

1

PUBCHEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DELSOLINE

8NCS5NCP4W

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (MIXED)

Targets:

Neuronal acetylcholine receptor subunit alpha-7

Conditions:

Delsoline is a Nicotinic receptor antagonist, ganglion blocker; exhibits weak affinity at brain α-bungarotoxin-sensitive nicotinic acetylcholine receptors.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1